Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
capecitabine (xeloda) (1 trial)
Breast Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (1 total)